B
Beijing Yuewei Medical Technology
Cardiac surgery interventional medical devices
About Beijing Yuewei Medical Technology
Beijing Yuewei Gene Technology Co., Ltd., also known as Microread Genetics, operates as a specialized firm in the molecular diagnostics sector, concentrating on the development and provision of multi-gene panel testing solutions. The company was established in December 2007 by Chen Chuguang, who currently serves as the chairman. Mr. Chen, holding a Master's degree in medical molecular biology from the Chinese Academy of Medical Sciences, transitioned from a research scientist role to entrepreneurship with the aim of translating scientific knowledge into practical, industrialized applications. Co-founder Guo Lihua, who also holds a Master's degree, serves as the General Manager.
The firm's core business revolves around a medium-throughput gene detection technology platform that combines PCR with capillary electrophoresis. This technical foundation enables the company to offer integrated solutions that encompass detection equipment, diagnostic reagents, and analysis software. The business model is structured to address the needs of two primary markets: forensic science and clinical medicine. In the forensic sector, Yuewei Gene provides a complete one-stop solution for public security DNA database construction and criminal case detection, covering everything from sample collection and preservation to analysis software. Their products in this area are utilized by public security bureaus across 28 provinces in China.
In the clinical diagnostics arena, the company is developing a product portfolio targeting major diseases related to oncology, genetic disorders, and cardiovascular conditions. A notable product is its microsatellite instability (MSI) gene detection kit, which was the first of its kind in China based on all mononucleotide loci. The firm has also secured registration for its GenReader 7010 gene analyzer. To expand its market reach in the clinical field, Yuewei Gene employs a direct sales force for academic promotion to hospitals and engages in strategic partnerships, including collaborations with companies like Thermo Fisher. The company has received multiple rounds of funding from prominent investors, including Sequoia China and RedHill Capital.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 22.0/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Oncology, Genetics and genomics, Health Diagnostics, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- B2B
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Apr 2025 | $14M | $55M | Shaanxi Fund | ↗ |
| SERIES A✓Equity / VC | Dec 2023 | $14M | $55M | IDG Capital · South China Venture Capital · Yuanhui Capital · Innolink Fund | ↗ |
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Beijing Yuewei Medical Technology in its local ecosystem
The Beijing Yuewei Medical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
IDG Capital- YCYuanhui Chuangyi
Series A5 investors entered at this stage
South China Venture Capital- YCYuanhui Capital
- IFInnolink Fund
- NCNoyu Capital
- SFShaanxi Fund
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Beijing Yuewei Medical Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Beijing Yuewei Medical Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








